Abiopharma

🔍 Patten Jarrod M (Executive)

Company: Strategy Inc (MSTR)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Acquired 1,500 shares of Class A Common Stock at $18.236 per share (Direct)
  Date: 2026-06-23 | Code: M | equity_swap_involved: false | shares_owned_after: 29,906.00 | transaction_form_type: 4
• Sold 1,500 shares of Class A Common Stock at $106.08 per share (Direct)
  Date: 2026-06-23 | Code: S | equity_swap_involved: false | shares_owned_after: 28,406.00 | transaction_form_type: 4
• Holds 0 shares of Series A Perpetual Strife Preferred Stock (Direct)
  Date: 2026-06-23 | Code: H | shares_owned_after: 10,000.00
• Holds 0 shares of Series A Perpetual Stretch Preferred Stock (Direct)
  Date: 2026-06-23 | Code: H | shares_owned_after: 29,335.00
• Holds 0 shares of Series A Perpetual Stride Preferred Stock (Direct)
  Date: 2026-06-23 | Code: H | shares_owned_after: 5,000.00
• Sold 1,500 shares of Director Stock Option (Right to buy) at $18.236 per share (Derivative)
  Date: 2026-06-23 | Code: M | Expires: 2027-05-31 | equity_swap_involved: false | shares_owned_after: 41,250.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The 1,500 shares exercised on June 23, 2026 pursuant to this option vested on May 31, 2018. Of the remaining 41,250 shares pursuant to this option, 3,750 shares vested on May 31, 2018, 12,500 shares vested on May 31, 2019, 12,500 shares vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.